167 related articles for article (PubMed ID: 27797804)
1. Everolimus-associated stomatitis in a patient who had renal transplant.
Ji YD; Aboalela A; Villa A
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27797804
[TBL] [Abstract][Full Text] [Related]
2. New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus.
Pasin VP; Pereira AR; Carvalho KA; Paiva JM; Enokihara MM; Porro AM
An Bras Dermatol; 2015; 90(3 Suppl 1):165-7. PubMed ID: 26312705
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Jones VE; McIntyre KJ; Paul D; Wilks ST; Ondreyco SM; Sedlacek S; Melnyk A; Oommen SP; Wang Y; Peck SR; O'Shaughnessy JA
Oncologist; 2019 Sep; 24(9):1153-1158. PubMed ID: 30833486
[TBL] [Abstract][Full Text] [Related]
4. Random Allocated Study of Wrapping Oblate for Prevention of Everolimus-associated Stomatitis in Patients With Metastatic Renal Cell Carcinoma.
Park K; Baek Y; Lee JL
Anticancer Res; 2019 Jul; 39(7):3937-3944. PubMed ID: 31262924
[TBL] [Abstract][Full Text] [Related]
5. Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
Velioglu A; Eryuksel E; Cimsit C; Tuglular S; Ozener C
Exp Clin Transplant; 2018 Aug; 16(4):491-494. PubMed ID: 27001620
[TBL] [Abstract][Full Text] [Related]
6. Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast Cancer.
Divers J; O'Shaughnessy J
Clin J Oncol Nurs; 2015 Aug; 19(4):468-74. PubMed ID: 26207713
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer patients have increased risk of developing mTOR inhibitor-associated stomatitis.
de Lima M; Hajj G; de Lima V; Alves FA
Oral Dis; 2018 Mar; 24(1-2):207-209. PubMed ID: 29480592
[TBL] [Abstract][Full Text] [Related]
8. Recommendations of everolimus use in liver transplant.
Rubín Suárez A; Bilbao Aguirre I; Fernández-Castroagudin J; Pons Miñano JA; Salcedo Plaza M; Varo Pérez E; Prieto Castillo M
Gastroenterol Hepatol; 2017 Nov; 40(9):629-640. PubMed ID: 28743539
[TBL] [Abstract][Full Text] [Related]
9. [Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation].
Caletti C; Granata S; Tomei P; Lupo A; Zaza G
G Ital Nefrol; 2014; 31(4):. PubMed ID: 25098457
[TBL] [Abstract][Full Text] [Related]
10. Use of everolimus following kidney transplantation during pregnancy: A case report and systematic review.
Chai PY; Lin C; Kao CC; Lin LM; Chen YH; Sun CY
Taiwan J Obstet Gynecol; 2023 Sep; 62(5):774-778. PubMed ID: 37679013
[TBL] [Abstract][Full Text] [Related]
11. Conversion to everolimus in maintenance patients--current clinical strategies.
Pohanka E
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii24-9. PubMed ID: 16815853
[TBL] [Abstract][Full Text] [Related]
12. Everolimus: a review of its use in renal and cardiac transplantation.
Dunn C; Croom KF
Drugs; 2006; 66(4):547-70. PubMed ID: 16597167
[TBL] [Abstract][Full Text] [Related]
13. Life-Threatening Everolimus-Associated Pneumonitis: A Case Report and a Review of the Literature.
Almeida F; Amorim S; Sarmento A; Santos L
Transplant Proc; 2018 Apr; 50(3):933-938. PubMed ID: 29588066
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.
Conteduca V; Santoni M; Medri M; Scarpi E; Burattini L; Lolli C; Rossi L; Savini A; Berardi R; Stanganelli I; Cascinu S; De Giorgi U
Clin Genitourin Cancer; 2016 Oct; 14(5):426-431. PubMed ID: 27021585
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus and everolimus in kidney transplantation.
Moes DJ; Guchelaar HJ; de Fijter JW
Drug Discov Today; 2015 Oct; 20(10):1243-9. PubMed ID: 26050578
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Stomatitis: Using Dexamethasone-Based Mouthwash to Inhibit Everolimus-Related Stomatitis.
Saigal B; Guerra L
Clin J Oncol Nurs; 2018 Apr; 22(2):211-217. PubMed ID: 29547614
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus.
Chuang P; Langone AJ
Am J Transplant; 2007 Mar; 7(3):714-7. PubMed ID: 17250555
[TBL] [Abstract][Full Text] [Related]
18. Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management.
Nicolatou-Galitis O; Nikolaidi A; Athanassiadis I; Papadopoulou E; Sonis S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):e110-6. PubMed ID: 23643584
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients.
Brunkhorst LC; Fichtner A; Höcker B; Burmeister G; Ahlenstiel-Grunow T; Krupka K; Bald M; Zapf A; Tönshoff B; Pape L
PLoS One; 2015; 10(9):e0135439. PubMed ID: 26407177
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.
Budde K; Becker T; Arns W; Sommerer C; Reinke P; Eisenberger U; Kramer S; Fischer W; Gschaidmeier H; Pietruck F;
Lancet; 2011 Mar; 377(9768):837-47. PubMed ID: 21334736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
